Differential Methylation in CITED4: Bladder Cancer Risk Biomarker?

Differential methylation in CITED4, as measured in blood, appears to be a promising marker of bladder cancer susceptibility in women.

Source: CancerNetwork - March 20, 2018 Category: Cancer & Oncology Authors: Anne Landry Tags: Bladder Cancer News Source Type: news